Background
The patent of Oliver Brüstle that is at stake relates to
purified neural precursor cells and to processes for their
production from embryonic stem cells. Neural precursor cells may be
used for the treatment of neural defects (like Parkinson's
disease), which use is also claimed in the patent. According to the
patent the embryonic stem cells from which the neural precursor
cells are created are pluripotent, which means that they have the
potential to develop into all kinds of cell types, but not into a
complete human being. Only so-called totipotent cells are capable
of developing into a human being.
Greenpeace is of the opinion that the subject matter of
Brüstle's patent is not patentable because it would
contravene public order and morality. Greenpeace argues that for
the application of the invention it is necessary to use pluripotent
embryonic stem cells, and that such stem cells can only be obtained
by destroying an human embryo (although this latter